Federal award (PURCHASE ORDER, fiscal year 2021)
Recipient: BIOINTRON BIOLOGICAL USA INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-09-07 to 2022-09-30
Current total value of award: $10932
Description: TWENTY ANTIBODIES EXPRESSED IN CELL CULTURE